The Kimberly and Eric J. Waldman Department of Dermatology is committed to excellence in research and patient care, offering high-level expertise in medical, surgical, and cosmetic dermatological conditions including eczema, alopecia areata, melanoma, cutaneous T-cell lymphoma, chronic itch disorders, psoriasis, vitiligo, and acne. Led by Emma Guttman-Yassky, MD, PhD, our team is conducting groundbreaking studies to develop new treatments with multiple clinical trials giving our patients access to innovative therapies. We have one of the most active teaching programs of any dermatology residency program in the nation. Recently, we were ranked #1 in Research Output on Doximity Residency Navigator.
The Kimberly and Eric J. Waldman Department of Dermatology is committed to excellence in research and patient care, offering high-level expertise in medical, surgical, and cosmetic dermatological conditions including eczema, alopecia areata, melanoma, cutaneous T-cell lymphoma, chronic itch disorders, psoriasis, vitiligo, and acne. Led by Emma Guttman-Yassky, MD, PhD, our team is conducting groundbreaking studies to develop new treatments with multiple clinical trials giving our patients access to new, innovative therapies. We have one of the most active teaching programs of any dermatology residency program in the nation. Recently, we were ranked #1 in Research Output on Doximity Residency Navigator.
Latest Content |view more
"Spotlighting Alopecia” with Emma Guttman-Yassky, MD, PhD
"Spotlighting Alopecia” with Emma Guttman-Yassky, MD, PhD, featured an in depth discussion with Louis DePalo, MD, from the Health Center at Hudson Yards.
The research training program in Systems Skin Biology will take a multidisciplinary approach in teaching scientists to holistically understand human physiology, health, and disease.
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped.
Brian S. Kim, MD, MTR, presented virtually as a keynote speaker, at the Anesthesiology Branch of Chinese Geriatric Society 2022 Annual Meeting, Tianjin, China. This popular presentation’s total online viewing clicks were more than 400,000 during the meeting.
Brian S. Kim, MD, MTR, received the inaugural Stephen I Katz, MD, PhD, International Lectureship Award and presented "Neuroimmune Regulation of Itch" at the Society for Investigative Dermatology (SID) annual meeting in Portland, Oregon in May 2022.
“Inflammatory Skin Diseases: The Translational Revolution” by Emma Guttman-Yassky, MD, PhD
Emma Guttman-Yassky, MD, PhD, discussed “Inflammatory Skin Diseases: The Translational Revolution” outlining her research which proposed a paradigm shift in the pathogenesis of atopic dermatitis.